Mirum Pharmaceuticals (MIRM) News
NASDAQ: MIRMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
86.01+4.66 (+5.73%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MIRM news summary
We found 1 recent headline mentioning Mirum Pharmaceuticals (MIRM): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. MIRM is making an outsized move today, up 5.73% at $86.01, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Mirum's Brelovitug Meets Goal in Phase III AZURE-1 Study in HDV", was published by Nasdaq on Sep 29, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology